What is the minimum age at which Lexapro (escitalopram) can be taken?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Minimum Age for Lexapro (Escitalopram)

Lexapro can be taken starting at age 7 for generalized anxiety disorder and age 12 for major depressive disorder, as these are the FDA-approved minimum ages for each indication. 1

FDA-Approved Age Indications

The FDA labeling clearly specifies two distinct age thresholds based on the condition being treated:

  • Generalized Anxiety Disorder (GAD): Approved for patients 7 years of age and older 1
  • Major Depressive Disorder (MDD): Approved for patients 12 years of age and older 2, 1

Lexapro is explicitly not approved for use in pediatric patients less than 7 years of age. 1

Dosing by Age and Indication

For GAD (Ages 7+)

  • Starting dose: 10 mg once daily 1
  • Maximum dose: 20 mg once daily 1
  • Dose increases: Can occur at intervals of no less than 2 weeks 1

For MDD (Ages 12+)

  • Starting dose: 10 mg once daily 2, 1
  • Maximum dose: 20 mg once daily 2, 1
  • Dose increases: Can occur at intervals of no less than 3 weeks 1

Supporting Evidence

The FDA approval for adolescents aged 12-17 years with depression is supported by clinical trial data, though the evidence base is limited. 3 A randomized controlled trial in pediatric patients ages 6-17 years showed that while escitalopram did not significantly improve depression scores in the total population, post-hoc analysis of adolescent completers (ages 12-17) demonstrated significant benefit. 4

For GAD, a multicenter trial confirmed escitalopram's efficacy and safety in children aged 7-11 years as well as adolescents aged 12-17 years, supporting the lower age threshold for anxiety disorders. 5

Critical Safety Considerations

All patients under age 25 require close monitoring for suicidal thoughts and behaviors, particularly during the first few months of treatment or when doses are changed. 1 The FDA black-box warning emphasizes that antidepressants increase the risk of suicidal ideation in pediatric and young adult patients. 1

Starting at higher than recommended doses increases the risk of deliberate self-harm and suicide. 2 Always initiate at 10 mg daily and increase gradually only if clinically indicated. 2, 1

References

Research

A review of escitalopram and citalopram in child and adolescent depression.

Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent, 2011

Research

A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression.

Journal of the American Academy of Child and Adolescent Psychiatry, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.